{"id":533751,"date":"2021-09-02T08:04:10","date_gmt":"2021-09-02T12:04:10","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/keros-therapeutics-to-participate-in-two-upcoming-healthcare-conferences\/"},"modified":"2021-09-02T08:04:10","modified_gmt":"2021-09-02T12:04:10","slug":"keros-therapeutics-to-participate-in-two-upcoming-healthcare-conferences","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/keros-therapeutics-to-participate-in-two-upcoming-healthcare-conferences\/","title":{"rendered":"Keros Therapeutics to Participate in Two Upcoming Healthcare Conferences"},"content":{"rendered":"<div class=\"mw_release\">\n<p>LEXINGTON, Mass., Sept.  02, 2021  (GLOBE NEWSWIRE) &#8212; Keros Therapeutics, Inc. (\u201cKeros\u201d) (Nasdaq: KROS), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel treatments for patients suffering from hematological and musculoskeletal disorders with high unmet medical need, today announced that Keros\u2019 President and Chief Executive Officer Jasbir S. Seehra, Ph.D., will participate in two upcoming healthcare conferences.<\/p>\n<p>\n        <strong>Presentation Details:<\/strong>\n      <\/p>\n<p>\n        <strong>Event:<\/strong> Morgan Stanley 19<sup>th<\/sup> Annual Global Healthcare Conference<br \/><strong>Date\/Time:<\/strong> Friday, September 10 at 11:00 AM ET<br \/><strong>Format:<\/strong> Fireside Chat<\/p>\n<p>\n        <strong>Event:<\/strong> H.C. Wainwright 23<sup>rd<\/sup> Annual Global Investment Conference<br \/><strong>Date\/Time:<\/strong> Available on Monday, September 13 starting at 7:00 AM ET<br \/><strong>Format:<\/strong> Corporate Presentation<\/p>\n<p>The Morgan Stanley fireside chat presentation will be webcast live at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=ugOQhCEKssyN9tjY0dP-wQOJqN2uaUhAtfDd80D2_MK-dHMUIYdL5fXlBx-Z5vkyYdOiFfms-SIANA72qhS5h0isLobbFiCfIsKuh0DIPhFawMYrioiFBkpQObxV5UjiUTJ0nOsF08368uB3Ei3SfA3Z_uWe9JaanwDQJM88A8aVPYZbqaUHljcSqzpwOYBgEweYAFNDhz3aMBFmWN8PMA0xg2pDQs10sysYYlawkBMyjEtHS_1SNNroS2DleGgh\" rel=\"nofollow noopener\" target=\"_blank\">https:\/\/morganstanley.webcasts.com\/starthere.jsp?ei=1488923&amp;tp_key=f6a26a9322<\/a> and the H.C. Wainwright presentation will be available at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=ugOQhCEKssyN9tjY0dP-wfJo4jF-EgM68dVuUx0bh_2iur3UQmytvRCuFYDjqt8V4sCcKZ46iebscvexzYuczEPXBHiRV4aYx6FnHqsXVecM5-JSb2tz0PVHGmpwS84XnmsPVpj4VaL4Hwhg9rbHHPSweLR-FbTr7w3kS0sxo3bDP5j0g0_y3EhHllcK6tPkEAJJdtZTU0M5yiwcegdJ6A==\" rel=\"nofollow noopener\" target=\"_blank\">https:\/\/journey.ct.events\/view\/2af63db8-a98e-40f7-bb4e-4fc6d4b18ba0<\/a>. Both will be archived in the Investors section of the Keros website at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=ugOQhCEKssyN9tjY0dP-wefgoeil-8aTw8Ol3S1sB_t5lKrpluZuqphNzteqX9gQ5JmyTHaEdPbUwiYfVlIY2DU2-4UHvSCZQhwsRJoTY98=\" rel=\"nofollow noopener\" target=\"_blank\">https:\/\/ir.kerostx.com\/<\/a>. A replay will be available for 90 days following the conclusion of the event.<\/p>\n<p>\n        <strong>About Keros Therapeutics, Inc.<\/strong>\n      <\/p>\n<p>Keros is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel treatments for patients suffering from hematologic and musculoskeletal disorders with high unmet medical need. Keros is a leader in understanding the role of the transforming growth factor-Beta, or TGF-\u00df, family of proteins, which are master regulators of red blood cell and platelet production as well as of the growth, repair and maintenance of muscle and bone. Keros\u2019 lead protein therapeutic product candidate, KER-050, is being developed for the treatment of low blood cell counts, or cytopenias, including anemia and thrombocytopenia, in patients with myelodysplastic syndromes and in patients with myelofibrosis. Keros\u2019 lead small molecule product candidate, KER-047, is being developed for the treatment of anemia resulting from iron imbalance, as well as for the treatment of fibrodysplasia ossificans progressiva. Keros\u2019 third product candidate, KER-012, is being developed for the treatment of disorders associated with bone loss, such as osteoporosis and osteogenesis imperfecta, and for the treatment of pulmonary arterial hypertension.<\/p>\n<p>\n        <strong>Investor Contact:<\/strong>\n      <\/p>\n<p>Mike Biega<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=T3sMvXw6tLGvUlqmG3LllAwTRC2XdwI-Fn5n9XHfD2c9Vkj3spNMIJvu0BrioexSICt4EIuKWRNm9uFiDwcnEVBeI4dyg_R1ckilDktM3L0=\" rel=\"nofollow noopener\" target=\"_blank\">mbiega@soleburytrout.com<\/a>\u00a0<br \/>(617) 221-9660<\/p>\n<p \/>\n      <img decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMxOTA2NiM0Mzg1NjE1IzIxMjU5MzM=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" src=\"https:\/\/ml.globenewswire.com\/media\/ZDAyNWZlYWUtYjBiNy00MWRmLWE1MjItZGJjZjUwNzZjZWMzLTExMzc1MDQ=\/tiny\/Keros-Therapeutics-Inc-.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>LEXINGTON, Mass., Sept. 02, 2021 (GLOBE NEWSWIRE) &#8212; Keros Therapeutics, Inc. (\u201cKeros\u201d) (Nasdaq: KROS), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel treatments for patients suffering from hematological and musculoskeletal disorders with high unmet medical need, today announced that Keros\u2019 President and Chief Executive Officer Jasbir S. Seehra, Ph.D., will participate in two upcoming healthcare conferences. Presentation Details: Event: Morgan Stanley 19th Annual Global Healthcare ConferenceDate\/Time: Friday, September 10 at 11:00 AM ETFormat: Fireside Chat Event: H.C. Wainwright 23rd Annual Global Investment ConferenceDate\/Time: Available on Monday, September 13 starting at 7:00 AM ETFormat: Corporate Presentation The Morgan Stanley fireside chat presentation will be webcast live at https:\/\/morganstanley.webcasts.com\/starthere.jsp?ei=1488923&amp;tp_key=f6a26a9322 and the H.C. Wainwright presentation will be available &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/keros-therapeutics-to-participate-in-two-upcoming-healthcare-conferences\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Keros Therapeutics to Participate in Two Upcoming Healthcare Conferences&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-533751","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.7 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Keros Therapeutics to Participate in Two Upcoming Healthcare Conferences - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/keros-therapeutics-to-participate-in-two-upcoming-healthcare-conferences\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Keros Therapeutics to Participate in Two Upcoming Healthcare Conferences - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"LEXINGTON, Mass., Sept. 02, 2021 (GLOBE NEWSWIRE) &#8212; Keros Therapeutics, Inc. (\u201cKeros\u201d) (Nasdaq: KROS), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel treatments for patients suffering from hematological and musculoskeletal disorders with high unmet medical need, today announced that Keros\u2019 President and Chief Executive Officer Jasbir S. Seehra, Ph.D., will participate in two upcoming healthcare conferences. Presentation Details: Event: Morgan Stanley 19th Annual Global Healthcare ConferenceDate\/Time: Friday, September 10 at 11:00 AM ETFormat: Fireside Chat Event: H.C. Wainwright 23rd Annual Global Investment ConferenceDate\/Time: Available on Monday, September 13 starting at 7:00 AM ETFormat: Corporate Presentation The Morgan Stanley fireside chat presentation will be webcast live at https:\/\/morganstanley.webcasts.com\/starthere.jsp?ei=1488923&amp;tp_key=f6a26a9322 and the H.C. Wainwright presentation will be available &hellip; Continue reading &quot;Keros Therapeutics to Participate in Two Upcoming Healthcare Conferences&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/keros-therapeutics-to-participate-in-two-upcoming-healthcare-conferences\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-09-02T12:04:10+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMxOTA2NiM0Mzg1NjE1IzIxMjU5MzM=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/keros-therapeutics-to-participate-in-two-upcoming-healthcare-conferences\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/keros-therapeutics-to-participate-in-two-upcoming-healthcare-conferences\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Keros Therapeutics to Participate in Two Upcoming Healthcare Conferences\",\"datePublished\":\"2021-09-02T12:04:10+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/keros-therapeutics-to-participate-in-two-upcoming-healthcare-conferences\\\/\"},\"wordCount\":368,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/keros-therapeutics-to-participate-in-two-upcoming-healthcare-conferences\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODMxOTA2NiM0Mzg1NjE1IzIxMjU5MzM=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/keros-therapeutics-to-participate-in-two-upcoming-healthcare-conferences\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/keros-therapeutics-to-participate-in-two-upcoming-healthcare-conferences\\\/\",\"name\":\"Keros Therapeutics to Participate in Two Upcoming Healthcare Conferences - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/keros-therapeutics-to-participate-in-two-upcoming-healthcare-conferences\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/keros-therapeutics-to-participate-in-two-upcoming-healthcare-conferences\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODMxOTA2NiM0Mzg1NjE1IzIxMjU5MzM=\",\"datePublished\":\"2021-09-02T12:04:10+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/keros-therapeutics-to-participate-in-two-upcoming-healthcare-conferences\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/keros-therapeutics-to-participate-in-two-upcoming-healthcare-conferences\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/keros-therapeutics-to-participate-in-two-upcoming-healthcare-conferences\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODMxOTA2NiM0Mzg1NjE1IzIxMjU5MzM=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODMxOTA2NiM0Mzg1NjE1IzIxMjU5MzM=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/keros-therapeutics-to-participate-in-two-upcoming-healthcare-conferences\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Keros Therapeutics to Participate in Two Upcoming Healthcare Conferences\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Keros Therapeutics to Participate in Two Upcoming Healthcare Conferences - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/keros-therapeutics-to-participate-in-two-upcoming-healthcare-conferences\/","og_locale":"en_US","og_type":"article","og_title":"Keros Therapeutics to Participate in Two Upcoming Healthcare Conferences - Market Newsdesk","og_description":"LEXINGTON, Mass., Sept. 02, 2021 (GLOBE NEWSWIRE) &#8212; Keros Therapeutics, Inc. (\u201cKeros\u201d) (Nasdaq: KROS), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel treatments for patients suffering from hematological and musculoskeletal disorders with high unmet medical need, today announced that Keros\u2019 President and Chief Executive Officer Jasbir S. Seehra, Ph.D., will participate in two upcoming healthcare conferences. Presentation Details: Event: Morgan Stanley 19th Annual Global Healthcare ConferenceDate\/Time: Friday, September 10 at 11:00 AM ETFormat: Fireside Chat Event: H.C. Wainwright 23rd Annual Global Investment ConferenceDate\/Time: Available on Monday, September 13 starting at 7:00 AM ETFormat: Corporate Presentation The Morgan Stanley fireside chat presentation will be webcast live at https:\/\/morganstanley.webcasts.com\/starthere.jsp?ei=1488923&amp;tp_key=f6a26a9322 and the H.C. Wainwright presentation will be available &hellip; Continue reading \"Keros Therapeutics to Participate in Two Upcoming Healthcare Conferences\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/keros-therapeutics-to-participate-in-two-upcoming-healthcare-conferences\/","og_site_name":"Market Newsdesk","article_published_time":"2021-09-02T12:04:10+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMxOTA2NiM0Mzg1NjE1IzIxMjU5MzM=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/keros-therapeutics-to-participate-in-two-upcoming-healthcare-conferences\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/keros-therapeutics-to-participate-in-two-upcoming-healthcare-conferences\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Keros Therapeutics to Participate in Two Upcoming Healthcare Conferences","datePublished":"2021-09-02T12:04:10+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/keros-therapeutics-to-participate-in-two-upcoming-healthcare-conferences\/"},"wordCount":368,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/keros-therapeutics-to-participate-in-two-upcoming-healthcare-conferences\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMxOTA2NiM0Mzg1NjE1IzIxMjU5MzM=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/keros-therapeutics-to-participate-in-two-upcoming-healthcare-conferences\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/keros-therapeutics-to-participate-in-two-upcoming-healthcare-conferences\/","name":"Keros Therapeutics to Participate in Two Upcoming Healthcare Conferences - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/keros-therapeutics-to-participate-in-two-upcoming-healthcare-conferences\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/keros-therapeutics-to-participate-in-two-upcoming-healthcare-conferences\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMxOTA2NiM0Mzg1NjE1IzIxMjU5MzM=","datePublished":"2021-09-02T12:04:10+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/keros-therapeutics-to-participate-in-two-upcoming-healthcare-conferences\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/keros-therapeutics-to-participate-in-two-upcoming-healthcare-conferences\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/keros-therapeutics-to-participate-in-two-upcoming-healthcare-conferences\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMxOTA2NiM0Mzg1NjE1IzIxMjU5MzM=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMxOTA2NiM0Mzg1NjE1IzIxMjU5MzM="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/keros-therapeutics-to-participate-in-two-upcoming-healthcare-conferences\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Keros Therapeutics to Participate in Two Upcoming Healthcare Conferences"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/533751","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=533751"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/533751\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=533751"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=533751"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=533751"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}